Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
EPA CPDat observed this chemical in 11 composition records across product categories including Laboratory supplies, Cleaning products and household care, Personal care.
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 5/100 (low) · high confidence.
Prevalence of SODIUM SULFATE in our catalog (fda_ndc).
Products
280
Typical roles
Catalog
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
The published evidence profile currently shaping this ingredient record.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 11 composition records across product categories including Laboratory supplies, Cleaning products and household care, Personal care. EPA CPDat classifies this chemical for functional uses including Flavouring and nutrient, Processing aids not otherwise specified, pH regulating agent.
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 0.14 %w/w
US
FDA
Crème mains hydratante concentrée Formule Norvégienne
Neutrogena
Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Maximum daily exposure: 13 mg
US
FDA
Route: OPHTHALMIC; Dosage form: SUSPENSION; Maximum daily exposure: 1 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Potency: 16.24 mg
US
FDA
FDA NDC lists this ingredient in 261 active drug products and 280 total products.
US
FDA
openFDA substance registry classifies this ingredient as chemical.